RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia

被引：5
|
作者：
Chow, Signy [1 ]
Tang, Kenny [2 ]
Al-Abri, Mahmood [2 ]
Hall, Victoria [3 ]
Tremblay-Lemay, Rosemarie [4 ,5 ]
Rashedi, Iran [6 ]
Tsui, Hubert [7 ,8 ]
Chan, Steven M. [9 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Div Med Oncol & Hematol, Dept Med, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[3] Univ Hlth Network, Transplant Infect Dis & Ajmera Transplant Ctr, Toronto, ON, Canada
[4] Toronto Gen Hosp, Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
[5] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Div Hematol Pathol, Dept Lab Med & Mol Diagnost, Toronto, ON, Canada
[7] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[8] Sunnybrook Hlth Sci Ctr, Div Hematol Pathol, Dept Lab Med & Mol Diagnost, Toronto, ON, Canada
[9] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
来源：
LEUKEMIA RESEARCH | 2021年 / 111卷
关键词：
D O I：
10.1016/j.leukres.2021.106735
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] RUNX1 together with DAT mutations predicted poor outcome in acute myeloid leukemia
    Xiao, Jinyan
    Xie, Jundan
    Zhou, Biqi
    Liu, Yujie
    Lu, Jing
    Jiang, Airui
    Yao, Hong
    Qiu, Qiaocheng
    Ding, Zixuan
    Xue, Shengli
    Tang, Xiaowen
    Qiu, Huiying
    Chen, Suning
    Shen, Hongjie
    Wu, Depei
    Xu, Yang
    LEUKEMIA & LYMPHOMA, 2023, 64 (05) : 951 - 961
  • [22] The role of RUNX1 DNA-Binding mutations in acute myeloid leukemia.
    Cammenga, J
    Putz, G
    Niebuhr, B
    Horn, S
    Bergholz, U
    Buchholz, F
    Stocking, C
    BLOOD, 2005, 106 (11) : 397A - 398A
  • [23] Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia
    Thomas, Melvin E.
    Qi, Wenqing
    Walsh, Michael P.
    Ma, Jing
    Westover, Tamara
    Abdelhamed, Sherif
    Ezzell, Lauren J.
    Rolle, Chandra
    Xiong, Emily
    Rosikiewicz, Wojciech
    Xu, Beisi
    Loughran, Allister J.
    Pruett-Miller, Shondra M.
    Janke, Laura J.
    Klco, Jeffery M.
    LEUKEMIA, 2024, 38 (05) : 991 - 1002
  • [24] Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia
    Melvin E. Thomas
    Wenqing Qi
    Michael P. Walsh
    Jing Ma
    Tamara Westover
    Sherif Abdelhamed
    Lauren J. Ezzell
    Chandra Rolle
    Emily Xiong
    Wojciech Rosikiewicz
    Beisi Xu
    Allister J. Loughran
    Shondra M. Pruett-Miller
    Laura J. Janke
    Jeffery M. Klco
    Leukemia, 2024, 38 : 991 - 1002
  • [25] Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients
    Zappasodi, P.
    Brociner, M.
    Merati, G.
    Nizzoli, M. E.
    Roncoroni, E.
    Boveri, E.
    Castagnola, C.
    Arcaini, L.
    ANNALS OF HEMATOLOGY, 2021, 100 (04) : 1111 - 1113
  • [26] Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients
    P. Zappasodi
    M. Brociner
    G. Merati
    M. E. Nizzoli
    E. Roncoroni
    E. Boveri
    C. Castagnola
    L. Arcaini
    Annals of Hematology, 2021, 100 : 1111 - 1113
  • [27] In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline
    Mendler, Jason H.
    Maharry, Kati
    Becker, Heiko
    Eisfeld, Ann-Kathrin
    Senter, Leigha
    Mrozek, Krzysztof
    Kohlschmidt, Jessica
    Metzeler, Klaus H.
    Schwind, Sebastian
    Whitman, Susan P.
    Khalife, Jihane
    Caligiuri, Michael A.
    Klisovic, Rebecca B.
    Moore, Joseph O.
    Carter, Thomas H.
    Marcucci, Guido
    Bloomfield, Clara D.
    HAEMATOLOGICA, 2013, 98 (08) : E92 - E94
  • [28] Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study
    Pelland, Andree-Anne
    Savard, Xavier
    Barabe, Frederic
    Laroche, Vincent
    Munger, Michael
    Gallagher, Genevieve
    Marcoux, Nicolas
    Cantin, Guy
    Chenard-Poirier, Maxime
    Delage, Robert
    Lalancette, Marc
    Lemieux, Christopher
    BLOOD, 2022, 140 : 3304 - 3305
  • [29] Clinical Relevance of the RUNX1 Mutation in Egyptian Patients With Primary Refractory Acute Myeloid Leukemia
    Rakha, Nahed Moawad
    Ahmed, Shaza
    Elsamee, Hanaa A.
    Mousa, Reham
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S260 - S260
  • [30] NATIONAL EXPERIENCE WITH THE USE OF VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
    Labrador, J.
    Saiz-Rodriguez, M.
    De Miguel, D.
    Vidriales, M. B.
    Perez-Encinas, M.
    Sanchez-Sanchez, M. J.
    Cuello, R.
    Roldan-Perez, A.
    Vives, S.
    Benzo-Callejo, G.
    Colorado, M.
    Garcia-Fortes, M.
    Sayas, M. J.
    Olivier, C.
    Recio, I
    Seri-Merino, C.
    Tormo, M.
    Vall-llovera, F.
    Foncillas, M. A.
    Montesinos, P.
    HAEMATOLOGICA, 2020, 105 : 56 - 56
12345